Shilpa Medicare Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Shilpa Medicare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 47% in 3 years; of every extra ₹100 of sales, ₹56 became extra profit. Higher than 95% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹173Over the last 3 years, every ₹100 of reported profit came with ₹173 of operating cash.
Higher than 80% of Healthcare companies in India.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 76% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 72% of Healthcare companies in India.
Cash Locked Ratio
₹42For every ₹100 of sales, ₹42 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹41 tied up three years earlier.
More money tied up than 81% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹56Sales grew 47% in 3 years; of every extra ₹100 of sales, ₹56 became extra profit.
Higher than 95% of Healthcare companies in India.
Asset Productivity Ratio
+47% / +28%In 3 years sales changed by +47% while total assets changed by +28%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.7×Debt due within a year is covered 0.7 times by its yearly operating cash.
Lower than 62% of Healthcare companies in India.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Lower than 60% of Healthcare companies in India.
Tangible Assets Ratio
81%Of every ₹100 the company owns, ₹81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 80% of Healthcare companies in India.
Tangible Net Worth Ratio
73%Of every ₹100 of net worth, ₹73 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 78% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Shilpa Medicare Limited owes ₹0.30 for every ₹1 it owns. Net profit rose 211% in the year to Mar 2026.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
61.1Investors pay ₹61.1 for every ₹1 of Shilpa Medicare Limited's yearly profit, higher than 78% of Healthcare companies in India.
P/B ratio
6.52The share price is 6.52 times Shilpa Medicare Limited's book value per share, higher than 71% of Healthcare companies in India.
Market cap
₹16,904 CrThe total market value of all of Shilpa Medicare Limited's shares at today's price (share price × number of shares), larger than 77% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹2,591 CrWhat Shilpa Medicare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹132.49Net worth divided by the number of shares. The share price of ₹864.30 is 6.5 times this, which is the P/B above.
Return on equity (ROE)
10.7%Shilpa Medicare Limited earned 10.7% on its shareholders' money over the last year, lower than 63% of Healthcare companies in India.
Owes vs Owns
0.30×Shilpa Medicare Limited owes ₹0.30 for every ₹1 it owns (low), lower than 67% of Healthcare companies in India.
Dividend yield
0.06%Shilpa Medicare Limited pays 0.06% of its share price as dividends a year, lower than 94% of dividend-paying Healthcare companies in India.
Revenue growth
+20%Revenue rose 20% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Profit growth
+211%Net profit rose 211% in the year to Mar 2026.
Profit margin
15.8%Shilpa Medicare Limited keeps ₹16 of every ₹100 of revenue as net profit.
Cash quality
1.4×Cash from Shilpa Medicare Limited's business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
5.8×Shilpa Medicare Limited's operating profit covered its interest costs 5.8 times in the year to Mar 2026.
Cash vs debt
Net debtShilpa Medicare Limited had ₹619 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Shilpa Medicare Limited's P/E ratio?
Investors pay ₹61.1 for every ₹1 of Shilpa Medicare Limited's yearly profit, higher than 78% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Shilpa Medicare Limited: ₹16,904 Cr ÷ ₹2,591 Cr (31 Mar 2026) = 6.5.
What is Shilpa Medicare Limited's return on equity?
Shilpa Medicare Limited earned 10.7% on its shareholders' money over the last year, lower than 63% of Healthcare companies in India.
How much does Shilpa Medicare Limited owe compared with what it owns?
Shilpa Medicare Limited owes ₹0.30 for every ₹1 it owns (low), lower than 67% of Healthcare companies in India.
Does Shilpa Medicare Limited pay a dividend?
Yes. Shilpa Medicare Limited pays 0.06% of its share price as dividends a year, lower than 94% of dividend-paying Healthcare companies in India.
Is Shilpa Medicare Limited's revenue growing?
Revenue rose 20% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.